Delivery Marijuana Taking Over Los Angeles

 19th April 2018  Marijuana News

Image Source

Los Angeles. The city of angels.

If you’ve ever been to L.A., you know this wonderful city has a myriad of things to offer. Not only that, Los Angeles is the second most populated city in the United States.

So, what does this mean?

Opportunity.

If you’re an advocate of cannabis and live in greater L.A., you’re going to want to know about Grassdoor.

As a name you’ll want to remember, Grassdoor will inevitably make its way into your daily lexicon in the very near future.

A similar concept to Uber Eats, Grassdoor delivers reliable city-wide marijuana delivery to LA, the world’s largest cannabis market.

Here are some facts on the legalization of marijuana:

With a 25% CAGR (compound annual growth rate), annual legal cannabis spending in the United States will increase from 10 billion USD to 50 billion USD within the next decade.

Powered by the best tech platform in the business, Grassdoor operates according to its three main principles:

SAFETY

GrassDoor drivers are professional, uniformed, and licensed. All of their delivery drivers pass an extensive background check.

RELIABILITY

Your order will arrive in 30 minutes or less or you’ll receive $25 off your next order. You can track your delivery on the Grass Door Real Time Map. Unlike the fragmented delivery service providers, Grassdoor has invested in technical and operational systems to ensure a consistent user experience.

QUALITY

Grass Door guarantees the freshest, highest quality cannabis products with a 100% money-back guarantee.

Image Source

According to a recent survey, 93% of consumers would opt for delivery over pick-up when given the option. There is no doubt that Grassdoor will continue to be in high demand as the service becomes more widely known.

Let’s take a closer look at how this app actually works.

The User App

The user app is engineered for ease-of-use, has low-friction order processing for sales, maintains saved requests for one-click re-ordering, and manages administrative processes.

The Driver/Provider App

The driver/provider app manages inventory, contains administrative tools for driver/provider, has order routing, a management system, earnings and geo-tracking.

Single Front-End User Interface

The interface is user-friendly, enables fast city-wide delivery, contains seamless payment and order tracking, and offer a variety of high-grade products.

Image Source

The app is designed for fast market entry with limited downside and huge upside potential. Ultimately, Grassdoor is a tech product, which means lower legal risk for operators.

Next time you sit down, either alone or with friends, and are craving some cannabis, considering using Grassdoor. They are safe, reliable, and guaranteed to deliver a quality product.

2.5 (50%) 6 votes

Save

Is It Time to Invest in Cannabis Stocks?

One Stock for the Coming Pot Boom
A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming green revolution,to the tune of an estimated $50 billion.
Learn How and Why to Invest With this FREE REPORT https://goo.gl/AjUbWy

Hemp legalization is sweeping over North America — 10 states plus Washington, D.C., have all legalized recreational versions over the last few years, and full legalization comes to Canada in October 2018.

Legal pot was worth $10 billion for the U.S. in 2017 alone. And since experts have projected the U.S. industry to skyrocket to $50 billion by 2026, it’s time for investors to start paying attention.
Free Market Watch Assist - Know When and Where to Invest https://goo.gl/Zpfjy7

Because whether or not you’re planning on ingesting any THC, you can’t deny the monumental investing opportunity that a potentially $50 billion industry represents.

But it’s also a relatively new industry. Untested, unproven.

Until now.
Do you remember when these investing trends were just “clouds in the sky”?Did you pick up Amazon at $15.31 a share?How many Netflix shares did you invest in at $1.85 each?You did get Disney at $1.84 a share — Right? NO?

Then you should not miss out on the next Millionaire Revelation that is sweeping our Country RIGHT NOW!

Don’t sit and sulk over your lost opportunity in a few years, like you are doing over the Bitcoin mega haul, no one wants to hear about it. You have your chance — Today — to make a difference in your future and the future of everyone who depends on you. Get off the couch now and do the research you need to make yourself RICH. Your 9–5 never will!

Should You Invest in Marijuana Stocks?

All you need to know to make an informed decision about investing in high-growth — but high-risk — marijuana stocks. Get the FREE REPORT HERE. https://goo.gl/Zpfjy7

$100 Bonus With A Referred Schwab Account https://goo.gl/vrm9Bp
This is my personal referral link and I do not qualify for any incentive for you using it.

Robinhood Investment will Give YOU One (1) FREE Stock - Just for Signing Up with their Company. More INFO HERE https://goo.gl/aq5gMM
-------------------------------
The 420 Cannabis Guru Free Money, Stocks, and Preferred Investment Account Recommendations
https://goo.gl/tkDmNB

-------------------------------

If you are just interested in the purchase of legal and medical cannabis - this is one of the best shops in the industry https://goo.gl/YZCj86
cannabis 
cannabis oils 
cannabis oil 
cannabis cup 
cannabis club 
cannabis news 
medicinal cannabis
cannabis side effects
cannabis strain reviews
free cannabis
marijuana plant identification
harmful effects of marijuana
marijuana side effects short and long term
cannabis marijuana side effects
effects of marijuana on body
bad effects of marijuana
negative effects of marijuana
side effects of marijuana on males
bad side effects of cannabis
is cannabis oil legal
pure cannabis oil for cancer
benefits of medicinal marijuana
medicinal cannabis oil
medicinal cannabis strains
benefits of medical marijuana
best medicinal cannabis strains
cannabis medical uses
marijuana strains and effects
cannabis strain guide
list of marijuana strains
marijuana strain library
all strains of cannabis
strain review marijuana
medical marijuana strains and uses

Creative Commons License Info: https://support.google.com/youtube/an...

COPYRIGHT DISCLAIMER:

Under Section 107 of the Copyright Act 1976, allowance is made for "fair use"
for purposes such as criticism, comment, news reporting, teaching, scholarship,
and research. Fair use is a use permitted by copyright statute that might
otherwise be infringing. Non-profit, educational or personal use tips the balance
in favor of fair use.

DISCLAIMER: This video and description contains affiliate links, which means that if you click on one of the product links, I’ll receive a small commission. This helps support the channel and allows us to continue to make videos like this. Thank you for the support!

#cannabis #trending #investing #MondayMotivation #MondayThoughts #CannabisCommunity #canada #cannabiscanada #greenlife #cannabiseducation #cannabisculture

Medical Cannabis Stocks Vs. Recreational Cannabis Stocks: Which Ones Should You Invest In?

Medical Cannabis Stocks Vs. Recreational Cannabis Stocks: Which Ones Should You Invest In?

How should investors evaluate marijuana stocks? 

Even as the sector racks up significant gains in the stock market, investor assessment of its stocks is still colored by past stereotypes. Here is a brief primer on the expected market for the stocks. 

Broadly the industry is divided into two markets: the market for medical marijuana and the one for recreational marijuana. As their names suggest, both have applications in different industries. Depending on an investor’s risk profile and time horizon, stocks for companies from both markets are attractive because they represent a growth opportunity, similar to the one that existed for tech stocks. 

According to a report released by research firm ArcView Market Research and BDS analytics, the overall share of the medical marijuana industry slid from 100% in 2013 to 71% in 2017. (It is important to note here that recreational marijuana was legalized in only two states back in 2013. As of this writing, nine states have completely legalized recreational marijuana.) By 2027, medical marijuana will be just 33% of the overall market states ArcView. Recreational marijuana is expected to account for the rest. 

10% Off All Purchases Coupon Code: Thanks10

Shop for CBD's FREE USPS Shipping*

How Should Investors Evaluate Medical Marijuana Stocks?      

Examples of companies involved in the use of marijuana for medical uses are GW Pharmaceuticals (GWPH), Tilray Inc. (TLRY), Corbus Pharmaceuticals (CRBP), Cara Therapeutics (CARA), and Zynerba Pharmaceuticals (ZYNE). 

Major pharmaceutical companies have yet to come into the market for drugs containing cannabinoid chemicals. But they have begun stacking up on the patents. Research last month stated that Sanofis Aventis (SNA) and Merck & Co. (MRK) are among the top cannabis-related patent holders.  

For the reductions to have a meaningful scale and market, however, pharmaceutical companies developing drugs with cannabis chemicals will have to spend extensively on research and contend with a phalanx of federal regulations before their products come to market. The balance sheet of GW Pharmaceuticals is a testament to this approach. In its latest earnings call, the company said its $1.1 million revenue increase was primarily driven by a sales bump in Sativex, a cannabis-based mouth spray. Its spending on research and development also increased by $8.1 million primarily due to expenses related to the program development related to Epidiolex, the first drug containing cannabis chemicals approved by the FDA. Finally, the company also increased its capital expenditures program by $6.6 million because of increased expenses related to the production of CBD.  

The medical marijuana industry will evolve in a manner similar to the pharmaceutical industry, according to NYU Professor Aswath Damodaran. He states that it is a “safe prediction” that medical marijuana will become legal in all states before recreational marijuana. 

The basic framework for evaluating medical marijuana stocks remains similar to that for the pharmaceutical industry, which means investors should focus on the company’s pipeline of drugs and spending on research. Because research in cannabis is relatively new, it is safe to assume that the payback for investors in this industry will be longer as compared to recreational marijuana. For context, consider that GW Pharmaceuticals spent 19 years researching cannabis chemicals before getting its first drug approval earlier this year. 

The medical marijuana industry primarily uses cannabinoid (CBD), a non-psychoactive chemical of the cannabis plant, which can be used to treat a variety of neurological disorders. For example, it is currently being used in tests to treat Post Traumatic Stress Disorders (PTSD) for soldiers returning from war. The Food and Drug Administration (FDA) has approved four drugs with chemicals from or similar to the ones found in the cannabis plant, including Epidiolex, a drug used to treat a rare and severe form of epilepsy in children. 

The agency has been fairly circumspect regarding inclusion and approval of drugs with cannabis. “The study of marijuana in clinical trial settings is needed to assess the safety and effectiveness of marijuana for the treatment of any disease or condition,” the agency writes on its website. However, a press release circulated by the agency after it approved the first CBD-infused drug cautions against “proliferation and marketing of unapproved CBD-containing products with unproven medical claims.” 

Medicines that incorporate marijuana might find significant applications in government healthcare. A 2016 research paper by Ashley Bradford and W. David Bradford from the University of Georgia found that prescription drug sales for painkillers “fell significantly” in states which legalized medical marijuana. “National overall reductions in Medicare program and enrollee spending when states implemented medical marijuana laws were estimated to be $165.2 million per year in 2013,” the authors wrote.

Meanwhile, other geographies might pick up the slack for medical marijuana from the American market. According to ArcView’s research, medical marijuana sales in Europe will dominate the marijuana market there. The research firm makes this claim based on the $1.3 trillion budget for the European healthcare market that is subsidized by governments. The South American medical cannabis market is also expected to grow from $125 million in 2018 to $227 million in 2027. 

How Should Investors Evaluate Recreational Marijuana Stocks?  

The most prominent example of recreational marijuana play is Canadian player Canopy Growth Corp. (CGC).  Even though medical marijuana was legalized first and already has a semblance of distribution infrastructure (in the form of medical dispensaries), recreational marijuana caters to a bigger audience and has greater recall in public memory. The head start translates into a potentially bigger market for this type of marijuana and is reflected in the exponential growth statistics for companies involved in this sector. However, federal legalization of recreational marijuana is essential before the market can reach its true potential. 

The recreational marijuana industry primarily uses THC (Tetrahydrocannabinol), a psychoactive agent that is responsible for the high which comes from smoking weed, for its products. It has multiple applications across products, from marijuana-infused beer to coffee and cigarettes. 

But the variety of products available for recreational marijuana comes with a catch in the form of hefty taxes charged by state governments. For example, Colorado charges 15 percent excise tax for sales from cultivators to retailers and another 15 percent sales tax. This makes the final marijuana product pretty expensive. Companies involved in recreational marijuana products will have to account for significant regulatory charges from governments on their balance sheets. 

Damodaran’s thesis states that illegal marijuana will still have a valid market due to high costs associated with its legal version. He states that the recreational marijuana industry “will grow with a wink and nod towards its side costs” and adds that it could also be a gateway to more potent and addictive substances. Social stigma against cannabis is also expected to play a role in overall sales for recreational marijuana products. Tobacco and alcohol, sectors which have to contend with similarly high taxes and reputation problems, have grown despite the problems. Bruce Linton, Canopy CEO, is optimistic about growth prospects for the cannabis market and told CNBC that recreational marijuana users will prefer to use the legal product instead of going back to street vendors.

Source https://www.investopedia.com/investing/medical-cannabis-stocks-vs-recreational-cannabis-stocks-which-ones-should-you-invest/